Ovintiv Inc. Form 4 Filings

Code Corey Douglas reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. EVP & CFO Corey Douglas received additional stock-based compensation in the form of dividend-equivalent awards. He was granted 337 Restricted Share Units, each economically equivalent to one share of Ovintiv common stock and subject to vesting under the Omnibus Incentive Plan.

Douglas also received 14 Deferred Share Units, which are held until retirement. After these awards, he directly holds 69,414 shares underlying RSUs and 2,863 shares underlying DSUs, reflecting routine compensation rather than any market purchase or sale.

Ovintiv Inc. director Ralph Izzo reported an acquisition of 33 Deferred Share Units (DSUs) tied to company dividends. Each DSU is the economic equivalent of one share of Ovintiv common stock and earns additional “dividend equivalent” DSUs. These 33 DSUs were received in lieu of cash dividends for the first quarter of 2026 and are held until retirement from the Board, bringing Izzo’s direct DSU balance to 6,892 units.

Ovintiv Inc. President & CEO Brendan Michael McCracken reported an acquisition of 1,109 Restricted Share Units (RSUs) that are each economically equivalent to one share of Ovintiv common stock and include dividend-equivalent RSUs for the first quarter of 2026.

Following this grant, McCracken directly holds 225,477 shares/RSUs. The RSUs vest and become exercisable under Ovintiv’s Omnibus Incentive Plan and the related grant agreement, contingent on his continued employment through the applicable exercise dates.

Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Sippy Chhina received 11 Deferred Share Units (DSUs) as a grant tied to first-quarter 2026 dividends. Each DSU is the economic equivalent of one Ovintiv common share and earns dividend-equivalent DSUs. After this award, Chhina directly holds 2,355 DSUs, which are kept until retirement from the Board.

Ovintiv Inc. executive Rachel Maureen Moore, EVP Corporate Services, received a grant of 182 Restricted Share Units on March 31, 2026. Each RSU is economically equivalent to one share of Ovintiv common stock and includes dividend equivalent RSUs for the first quarter of 2026.

The RSUs will vest and become exercisable under Ovintiv’s Omnibus Incentive Plan and the related grant agreement, subject to her continued employment through the applicable exercise dates. Following this award, Moore directly holds 37,488 shares or share-equivalent units in total.

Ovintiv Inc. executive vice president, marketing & midstream and general counsel Meghan Nicole Eilers sold 11,582 shares of Ovintiv common stock in an open-market transaction at $54.78 per share. Following this sale, she directly holds 54,092 Ovintiv shares, maintaining a substantial personal equity stake.

Ovintiv Inc. executive Meghan Nicole Eilers, EVP, M&M & GC, filed an amended insider report updating her common stock holdings. The Form 4/A shows an acquisition entry of 9,739 shares of common stock at $0.00 per share tied to vested long-term incentive awards. After this correction, she is shown holding 65,674 shares directly. A footnote explains that an earlier Form 3 had underreported these vested shares and that no new transactions occurred, making this a disclosure correction rather than fresh trading activity.

Ovintiv Inc. President & CEO Brendan Michael McCracken filed an amended insider report updating his common stock holdings. The filing records an acquisition entry of 962 shares of common stock, bringing his directly held position to 297,192 shares. According to the disclosure, he recently became aware of these 962 additional shares, which had not been included in earlier Section 16 reports, so this amendment is meant to align reported ownership with his actual holdings rather than reflect a new purchase or award.

Ovintiv Inc. EVP, Corporate Services Rachel Maureen Moore exercised equity awards and adjusted her holdings through compensation-related transactions. On March 9, 2026 and March 10, 2026, she exercised a total of 29,149 Restricted Share Units and Performance Share Units into common stock, with each unit converting one-for-one.

The Performance Share Units were settled using a performance multiplier of 84%. To cover tax obligations, 8,208 shares of common stock were withheld at prices of $52.46 and $52.92 per share, and 12,053 shares were disposed of to the issuer. Following these transactions, she directly holds 80,283 shares of common stock and 37,306 RSUs, plus 9,022 shares held indirectly in an RRSP.

Ovintiv Inc. EVP & CFO Corey Douglas reported a series of equity-compensation transactions as RSUs and PSUs vested and converted into common stock. Over March 9–10, he exercised or settled derivative awards covering 55,576 shares of common stock. To cover tax obligations, Ovintiv withheld a total of 15,830 shares of common stock at prices around $52–53 per share, and an additional 22,598 shares were returned to the issuer. After these transactions, Douglas directly holds 160,607 shares of Ovintiv common stock and indirectly holds 939 shares through a TFSA account.

Ovintiv Inc. EVP Meghan Nicole Eilers reported compensation-related equity activity involving restricted and performance share units. On March 9–10, 2026, she exercised and settled RSUs and PSUs into a total of 37,536 shares of common stock, all at a conversion price of $0.00 per share in line with the company’s incentive plans.

To cover tax obligations arising from these vestings, 7,443 shares were withheld at prices around the low-$50s per share, and 15,421 shares were returned to Ovintiv in an issuer disposition. Following these transactions, she directly holds 55,935 shares of common stock and indirectly holds 4,436 shares through a 401(k) plan, with no open-market purchases or sales reported.

Ovintiv Inc. EVP & COO Gregory Dean Givens reported compensation-related share activity involving restricted and performance share units. On March 9–10, he exercised RSUs and PSUs that converted into a total of 71,073 shares of Ovintiv common stock, consistent with the company’s Omnibus Incentive Plan and related grant agreements.

To cover tax withholding obligations, 15,831 shares of common stock were withheld, including shares issued upon RSU and PSU settlement at prices of $52.07 and $52.62 per share. After these transactions, Givens directly holds 130,266 shares of Ovintiv common stock and indirectly holds 2,813 shares through a 401(k) plan.

Ovintiv Inc. President & CEO Brendan Michael McCracken reported equity compensation activity involving restricted and performance share units that vested into common stock. On March 9–10, 2026, he exercised or settled awards covering 188,687 share-based units into Ovintiv common stock, as reflected in the filing’s exerciseShares figure.

To cover tax obligations on these vestings, Ovintiv withheld an aggregate of 47,695 shares at per-share values of $52.07 and $52.62, recorded as F-code tax-withholding dispositions rather than open-market sales. Following these transactions, McCracken directly held 296,230 shares of Ovintiv common stock, plus smaller indirect holdings of 1,808 shares in a 401(k) plan and 193 shares in an RRSP.

The footnotes explain that each restricted share unit and performance share unit is economically equivalent to one common share and converts on a one-for-one basis, with performance share units settled based on achievement of specified performance criteria, including an 84% performance multiplier for this settlement. No remaining derivative awards are shown after these exercises.

Ovintiv Inc. EVP & CFO Corey Douglas Code reported equity compensation awards in the form of restricted share units (RSUs). On March 5, 2026, he received three separate awards of 10,524 RSUs each at a price of $0.00 per unit.

Each RSU is the economic equivalent of one share of Ovintiv common stock and also earns dividend-equivalent RSUs. The RSUs vest on future exercise dates in line with the company’s Omnibus Incentive Plan and the grant agreements, and require his continued employment with Ovintiv through those exercise dates.

Ovintiv Inc. President and CEO Brendan Michael McCracken reported equity compensation in the form of restricted share units. On the reported date, he received three awards of 34,375 Restricted Share Units each, totaling 103,125 RSUs. Each RSU is economically equivalent to one share of Ovintiv common stock and accrues dividend-equivalent RSUs. Vesting will occur on specified exercise dates in line with Ovintiv's Omnibus Incentive Plan and the related grant agreements, and depends on his continued employment through those dates.

Ovintiv Inc. executive Meghan Nicole Eilers, EVP, M&M & GC, reported awards of Restricted Share Units on 2026-03-05. Each RSU is the economic equivalent of one share of Ovintiv common stock and also yields dividend-equivalent RSUs.

The filing records three grants of 7,202 Restricted Share Units each at a price of $0.0000 per unit, increasing her directly owned RSU balances to 54,173, 61,375, and 68,577 in the respective line items. Vesting will occur on the exercise date under Ovintiv’s Omnibus Incentive Plan, subject to her continued employment.

Ovintiv Inc. executive Rachel Maureen Moore, EVP Corporate Services, received equity awards in the form of restricted share units. On March 5, 2026, she acquired three separate grants of 5,980 Restricted Share Units each at a price of $0.00 per unit.

Each RSU is economically equivalent to one share of Ovintiv common stock and also provides dividend-equivalent RSUs. The awards vest on future exercise dates in line with Ovintiv’s Omnibus Incentive Plan and the related grant agreements, subject to her continued employment through the applicable vesting dates.

Ovintiv Inc. executive vice president and chief operating officer Gregory Dean Givens reported equity compensation in the form of restricted share units. On March 5, 2026, he received three grants of 11,458 Restricted Share Units (RSUs) each, at a stated price of $0.00 per unit.

Each RSU is the economic equivalent of one share of Ovintiv common stock and also yields dividend equivalent RSUs. Vesting will occur on the exercise date in line with Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement, and requires continued employment through the relevant exercise date.

Ovintiv Inc. director Howard John Mayson reported an open-market sale of company stock. On March 3, 2026, he sold 5,000 shares of Ovintiv common stock at a price of $52.39 per share. After this transaction, he directly owns 45,780 common shares of Ovintiv.

Ovintiv Inc. executive Gregory Dean Givens reported compensatory share movements. On February 27, 2026, he exercised Stock Appreciation Rights equivalent to 15,058 shares of common stock at an exercise price of $35.80 per share, then disposed of 15,058 common shares to the issuer at $50.59 per share. After these transactions, he directly owned 105,867 shares of Ovintiv common stock.

Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Sippy Chhina reported receiving a grant of 484 Deferred Share Units (DSUs) on February 27, 2026. Each DSU is economically equivalent to one Ovintiv common share and accrues dividend-equivalent DSUs. Following this award, Chhina directly holds 2,344 DSUs, which are retained until retirement from the Board.

IZZO RALPH reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Ralph Izzo reported an equity compensation grant in the form of deferred share units. He was awarded 482 Deferred Share Units (DSUs) on February 27, 2026, bringing his direct holdings of DSUs to 6,859. Each DSU is economically equivalent to one share of Ovintiv common stock and also earns dividend-equivalent DSUs, which accumulate over time. These DSUs are held until Mr. Izzo retires from the Board, aligning a portion of his compensation with the company’s long-term share performance.

Ovintiv Inc. director Meg Gentle reported an acquisition of Deferred Share Units on a Form 4. On this date, she received a grant of 582 Deferred Share Units, each economically equivalent to one share of Ovintiv common stock and yielding dividend-equivalent units. Following this grant, her reported holdings of Deferred Share Units total 11,284, which are held until retirement from the Board.

Ovintiv Inc. director files amended Form 4 to correct share amount received in a prior transaction. The reporting person now reports acquiring 19,742 shares of Ovintiv common stock on February 3, 2026 in connection with the NuVista plan of arrangement, at a price of $38.27 per share.

The earlier filing had shown 34,160 shares for this transaction, and this amendment states that 19,742 is the correct figure after final verification. Following the corrected transaction, the director beneficially owns 63,051 Ovintiv common shares directly.

Ovintiv Inc. director Brian Gordon Shaw reported receiving additional Ovintiv shares through a share exchange. On February 3, 2026, he acquired approximately 34,160 shares of Ovintiv common stock at a per share acquisition cost of $38.27 in connection with the exchange of NuVista Energy Ltd. shares under a plan of arrangement.

Following this transaction, he beneficially owned 77,469 Ovintiv common shares directly. The filing notes that both the share amount and per share cost reflect the best information available as of the filing date and that final figures remain subject to confirmation, with any necessary adjustments to be reported on a future Form 5.

Ovintiv Inc. director reported a routine equity change involving deferred share units. On 12/31/2025, the director acquired 408 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and will be held until the director retires from the Board.

Following this transaction, the director beneficially owned 54,019 derivative securities in the form of DSUs, held directly.

Ovintiv Inc. director reports dividend-equivalent deferred share units. A board member of Ovintiv Inc. filed a Form 4 showing an acquisition of 48 Deferred Share Units (DSUs) on 12/31/2025. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs, which are held until the director retires from the Board.

The 48 DSUs were received in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the director beneficially owns 6,377 derivative securities in the form of DSUs, held in direct ownership.

Ovintiv Inc.'s President & CEO, who also serves as a director, reported an equity transaction on 12/31/2025. The insider acquired 1,733 restricted share units (RSUs), each economically equivalent to one share of Ovintiv common stock. These RSUs were received as dividend equivalent RSUs in lieu of cash dividends for the fourth quarter of 2025.

The RSUs vest and become exercisable according to Ovintiv's Omnibus Incentive Plan and the applicable grant agreement, on the same schedule as the underlying RSUs and subject to continued employment with Ovintiv. Following this transaction, the insider beneficially owns 230,254 derivative securities, held directly.

Ovintiv Inc. reported an insider equity transaction by an executive officer. The reporting person, identified as an officer with the title EVP, M&M & GC, filed as a single reporting person for a transaction dated 12/31/2025. The filing shows an award of 354 restricted share units (RSUs) classified as derivative securities in Table II. Each RSU represents the economic equivalent of one share of Ovintiv common stock and includes dividend equivalent RSUs, vesting and becoming exercisable under Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment. The 354 RSUs represent dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the reporting person beneficially owned 46,971 derivative securities in the form of RSUs, held as a direct ownership position.

Ovintiv Inc. director reported a routine equity compensation change involving deferred share units. On 12/31/2025, the director acquired 81 Deferred Share Units (DSUs), which are each the economic equivalent of one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and will be held until the director retires from the Board.

Following this transaction, the director beneficially owns 10,702 derivative securities in the form of DSUs, held directly. The filing indicates the transaction was reported on behalf of the director under a power of attorney, reflecting standard insider reporting requirements rather than a discretionary open-market trade.

Ovintiv Inc. executive reports dividend-equivalent RSUs

Ovintiv Inc.'s EVP & COO reported receiving 630 restricted share units (RSUs) on 12/31/2025. These RSUs were granted as dividend-equivalent units in lieu of cash dividends for the fourth quarter of 2025 and are economically equal to 630 shares of Ovintiv common stock. The filing shows a total of 83,727 derivative securities beneficially owned after this transaction, all held directly. The RSUs will vest and become exercisable under Ovintiv's Omnibus Incentive Plan and the related grant agreement, subject to the executive's continued employment through the applicable exercise dates.

Ovintiv Inc. director reported a routine equity transaction involving deferred share units. On 12/31/2025, the director acquired 76 Deferred Share Units (DSUs), which are derivative securities that each represent the economic equivalent of one share of Ovintiv common stock and generate additional DSUs on dividends. These 76 DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the director beneficially owns 9,980 derivative securities in the form of DSUs, which are held until retirement from the Board.

Ovintiv Inc. director reports additional deferred share units from dividends. On 12/31/2025, the reporting person acquired 14 Deferred Share Units (DSUs), which are each the economic equivalent of one share of Ovintiv common stock and generate dividend-equivalent DSUs. These units were received in lieu of cash dividends for the fourth quarter of 2025 and are held until the director retires from the Board. Following this transaction, the director beneficially owns 1,860 DSUs on a direct basis.

Ovintiv Inc.'s Executive Vice President and Chief Financial Officer reported routine equity-based compensation tied to the company’s common stock. On 12/31/2025, the officer acquired 533 Restricted Share Units (RSUs), which are each economically equivalent to one share of Ovintiv common stock and include dividend-equivalent RSUs. Following this transaction, the officer held 70,483 RSUs in total.

The officer also acquired 22 Deferred Share Units (DSUs) on the same date, bringing total DSU holdings to 2,849 units. Both the RSUs and DSUs were credited as dividend equivalents received in lieu of cash dividends for the fourth quarter of 2025. RSU vesting and exercisability follow Ovintiv’s Omnibus Incentive Plan and the related grant agreement, while DSUs are held until retirement from the company.

Ovintiv Inc. executive reports dividend equivalent RSUs on Form 4. An officer of Ovintiv Inc., serving as EVP, Corporate Services, reported an acquisition of 276 restricted share units (RSUs) on 12/31/2025. Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

The 276 RSUs were credited as dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2025, at a stated price of $0. Following this transaction, the reporting person beneficially owned 36,461 derivative securities in the form of RSUs, held directly. Vesting and exercise of these RSUs will occur under Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement, subject to the executive’s continued employment through the relevant exercise dates.

Ovintiv Inc. director reported a routine change in equity holdings through deferred share units. On 12/31/2025, the director acquired 280 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and are held until retirement from the Board. Following this transaction, the director beneficially owns 36,982 DSUs, held in a direct capacity.

Ovintiv Inc. reported an insider transaction by an officer who serves as EVP & COO, who disposed of 50,000 shares of common stock on 12/12/2025 at a price of $40.33 per share in a transaction coded "S" and marked as a disposition.

After this transaction, the officer beneficially owned 105,867 shares of Ovintiv common stock held directly. The report was signed on behalf of the reporting person by Dawna Gibb under a power of attorney.

Ovintiv Inc. executive reports stock option exercises and share sales. On 12/11/2025, the company’s EVP & CFO exercised stock options covering 6,997 shares of common stock at $34.63 per share and 27,843 shares at $32.71 per share. On the same date, he sold 6,997 shares and 27,843 shares of Ovintiv common stock at $41.72 per share. Following these transactions, he beneficially owned 142,389 shares of Ovintiv common stock in direct form. The options were originally awarded and the sales executed in Canadian dollars, with the reported prices converted to U.S. dollars using the Bank of Canada exchange rate on the transaction date.

Ovintiv Inc. reported an insider transaction by a director. On 12/08/2025, an indirect holding of 5,000 shares of Ovintiv common stock was sold at a price of $41.99 per share, coded as an open-market or similar sale (transaction code "S").

The shares were held indirectly through the S&E Nance Trust, which remains the beneficial owner of 3,929 Ovintiv shares after the sale. The filing is made on behalf of a single reporting person and reflects a routine update to that person’s equity ownership in the company.

Ovintiv Inc. director reports gifted share transfer

A director of Ovintiv Inc. (OVV) reported an indirect transfer of common stock on December 5, 2025. According to the filing, the reporting person gave 900 shares of Ovintiv common stock as a gift, moving the shares from the Ricks Family Trust to family members at a stated price of $0 per share. Following the transaction, the filing shows the Ricks Family Trust holding 92,669 Ovintiv common shares indirectly for the reporting person.

Ovintiv Inc. executive reports stock appreciation right exercise and share sale. An officer of Ovintiv Inc. (ticker OVV), serving as EVP, M&M & GC, reported transactions dated 12/05/2025. The officer exercised 3,710 stock appreciation rights at an exercise price of $35.80 per right, receiving 3,710 shares of common stock. On the same date, 3,710 shares of common stock were disposed of at a price of $42.28 per share. Following these transactions, the officer directly beneficially owns 41,263 shares of Ovintiv common stock.

Ovintiv Inc. executive EVP & COO reported selling 50,000 shares of common stock on December 4, 2025, at a price of $42.50 per share. After this open-market sale, the reporting person directly holds 155,867 Ovintiv shares. The filing is a Form 4, meaning it discloses insider trading activity by a company officer rather than any new securities issuance by the company itself.

Ovintiv Inc. executive reports stock transaction and option exercise

Ovintiv Inc.'s Executive Vice President and Chief Operating Officer reported transactions in company stock. On 12/04/2025, the executive exercised 17,826 stock appreciation rights with an exercise price of $22.95 per right, receiving an equivalent number of Ovintiv common shares. On the same date, the executive disposed of 17,826 common shares at a reported price of $42.32 per share. After these transactions, the executive directly beneficially owns 205,867 shares of Ovintiv common stock.

Ovintiv Inc. reported an insider stock transaction by its President & CEO, who is also a director. On 12/04/2025, the executive exercised stock appreciation rights to acquire 10,373 shares of Ovintiv common stock at an exercise price of $35.80 per share. These rights were originally granted on 03/08/2019 and were scheduled to expire on 03/08/2026, and the exercise reduced the remaining balance of these derivative awards to zero.

On the same date, the executive sold 10,323 Ovintiv common shares at a price of $42.32 per share. After these transactions, the executive directly held 234,689 shares of Ovintiv common stock. Each stock appreciation right represented the economic equivalent of one share of Ovintiv common stock.

Ovintiv Inc. (OVV) executive vice president of Corporate Services reported a routine stock transaction. On 11/19/2025, the officer exercised 6,427 stock options for Ovintiv common shares at an exercise price of $33.98 per share, then sold 6,427 common shares on the same date at a price of $38.92 per share. After these transactions, the reporting person directly owned 70,163 Ovintiv common shares. The option award and sale prices were originally denominated in Canadian dollars and converted to U.S. dollars using the Bank of Canada exchange rate on the transaction date.

Ovintiv Inc. (OVV) disclosed a director’s equity award on a Form 4. On 11/10/2025, the reporting person acquired 611 Deferred Share Units (DSUs) at a stated price of $0, bringing derivative holdings to 6,329 DSUs, held in direct ownership.

Each DSU is the economic equivalent of one share of common stock, accrues dividend-equivalent DSUs, and is held until retirement from the Board.

Ovintiv Inc. (OVV) director reported an equity award on a Form 4. On 11/10/2025, the reporting person acquired 606 Deferred Share Units (DSUs) at $0. Following this transaction, the person beneficially owns 1,846 derivative securities.

Each DSU is economically equivalent to one share of Ovintiv common stock and accrues dividend-equivalent DSUs. The filing notes DSUs are held until retirement from the Board. Ownership is reported as Direct (D).

Ovintiv Inc. (OVV) reported a director’s equity transaction on Form 4. On November 10, 2025, the reporting person acquired 740 Deferred Share Units (DSUs) at a reported price of $0, reflecting a board equity award rather than an open‑market purchase. Following this grant, the reporting person beneficially owns 10,621 derivative securities, held directly.

Each DSU is the economic equivalent of one share of Ovintiv common stock, accrues dividend‑equivalent DSUs, and is held until the individual retires from the Board.